Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04157088
Title Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC) (DaroAcT)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Darolutamide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.